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Abstract
Background:  DNA methylation plays an important role in development and tumorigenesis by epigenetic
modification and silencing of critical genes. The development of PCR-based methylation assays on bisulphite
modified DNA heralded a breakthrough in speed and sensitivity for gene methylation analysis. Despite this
technological advancement, these approaches require a cumbersome gene by gene primer design and
experimental validation. Bisulphite DNA modification results in sequence alterations (all unmethylated cytosines
are converted into uracils) and a general sequence complexity reduction as cytosines become underrepresented.
Consequently, standard BLAST sequence homology searches cannot be applied to search for specific methylation
primers.
Results: To address this problem we developed methBLAST, a sequence similarity search program, based on the
original BLAST algorithm but querying in silico bisulphite modified genome sequences to evaluate oligonucleotide
sequence similarities. Apart from the primer specificity analysis tool, we have also developed a public database
termed methPrimerDB for the storage and retrieval of validated PCR based methylation assays. The web interface
allows free public access to perform methBLAST searches or database queries and to submit user based
information. Database records can be searched by gene symbol, nucleotide sequence, analytical method used,
Entrez Gene or methPrimerDB identifier, and submitter's name. Each record contains a link to Entrez Gene and
PubMed to retrieve additional information on the gene, its genomic context and the article in which the
methylation assay was described. To assure and maintain data integrity and accuracy, the database is linked to
other reference databases. Currently, the database contains primer records for the most popular PCR-based
methylation analysis methods to study human, mouse and rat epigenetic modifications. methPrimerDB and
methBLAST are available at http://medgen.ugent.be/methprimerdb and http://medgen.ugent.be/methblast.
Conclusion: We have developed two integrated and freely available web-tools for PCR based methylation
analysis. methBLAST allows in silico assessment of primer specificity in PCR based methylation assays that can be
stored in the methPrimerDB database, which provides a search portal for validated methylation assays.
Published: 09 November 2006
BMC Bioinformatics 2006, 7:496 doi:10.1186/1471-2105-7-496
Received: 21 March 2006
Accepted: 09 November 2006
This article is available from: http://www.biomedcentral.com/1471-2105/7/496
© 2006 Pattyn et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Bioinformatics 2006, 7:496 http://www.biomedcentral.com/1471-2105/7/496
Page 2 of 9
(page number not for citation purposes)
Background
Alterations in the patterns of DNA methylation are among
the earliest and most common events in tumorigenesis
[1,2]. In the mammalian genome, methylation takes place
mostly at cytosine bases that are located 5' to a guanosine
in a CpG dinucleotide. While this dinucleotide is gener-
ally underrepresented in the genome, short regions are
found that are rich in CpG content. Such CpG-rich regions
are part of gene promoters and are coined CpG islands [3].
Both global hypomethylation and regional promoter
hypermethylation have been described in a wide spec-
trum of cancers [4]. Hypomethylation (or absence of
methylation) of CpG islands increases potential gene
activity, whereas hypermethylation of these promoter-
containing CpG islands is associated with decreased gene
activity or silencing [5]. The development of efficient and
accurate methods to study cytosine methylation is there-
fore of critical importance in understanding the role of
DNA methylation in the development and progression of
cancer. Furthermore, methylation markers open perspec-
tives for earlier detection of malignancies and possible
better prognostic assessment of the patients [6].
Several methods have been described for evaluation of
cytosine methylation including digestion of DNA with
methylation-sensitive restriction enzymes followed by
Southern blotting or polymerase chain reaction (PCR) [7].
Southern blotting requires large amounts of high molecu-
lar weight DNA, which limits the use of this technique.
The above mentioned limitations are counteracted by per-
forming PCR, but still both methods rely on a complete
enzymatic digestion of the DNA in order to prevent false-
positive results.  Instead of using methylation-sensitive
restriction enzymes, other methods are based on sodium
bisulphite treatment of the DNA to introduce methyla-
tion-dependent sequence differences into the genomic
DNA. Sodium bisulphite converts unmethylated cytosine
to uracil while leaving 5-methylcytosine unchanged.
Nowadays, the most frequently used DNA methylation
analysis methods employ a combination of bisulphite
treatment and PCR.  The methylation-sensitive single-
nucleotide primer extension (Ms-SNuPE) method incor-
porates amplification of bisulphite-treated DNA, fol-
lowed by a quantification of the ratio of methylated versus
unmethylated cytosines at CpG sites [8].  An alternative
method, called combined bisulphite restriction analysis
(COBRA), uses standard sodium bisulphite PCR treat-
ment followed by restriction digestion and a quantitation
step [9].  A more widespread procedure combines a bisul-
phite treatment and PCR-single-strand conformation pol-
ymorphism analysis (Bisulphite-PCR-SSCP or BiPS) [10].
In a first step, the converted DNA is amplified with prim-
ers that have no CpG sites in the corresponding region of
the original DNA, and as such amplify both unmethylated
and methylated DNA. Sequence differences between
amplified products from unmethylated and methylated
DNA are visualised on a SSCP gel.  The fourth and one of
the most popular methods is methylation-specific PCR
(MSP) [11]. It heralded a breakthrough in speed and sen-
sitivity for gene methylation analysis. After bisulphite
conversion, PCR is performed using primers that distin-
guish methylated from unmethylated DNA. Unlike the
procedures using restriction enzymes, MSP can be used to
analyse any specific CpG site by appropriate primer
design and it is not prone to false-positive results. MSP is
very sensitive, permitting the analysis of small and heter-
ogeneous samples, including paraffin-embedded mate-
rial.  A fifth method applies the use of a sequencing
strategy to analyse the methylation status a target
sequence (bisulphite sequencing or BiSeq) [12]. Bisul-
phite converted DNA is amplified by PCR and subse-
quently sequenced to assess the methylation status of
individual CpG's by sequence comparison with a refer-
ence sequence. A cloning step is introduced before the
sequencing if the starting material contains a mixture of
cells with different methylation levels.  Although the
above described PCR-based DNA methylation analysis
methods are easy to use, sensitive and specific, the design
and experimental validation/optimisation of the primers
is often difficult, labour intensive, and excludes a certain
level of standardization and uniformity. To reduce the
number of difficult or even unsuccessful experimental
PCR optimizations, we developed methBLAST to quickly
assess the specificity of a primer pair prior to the experi-
mental evaluation step, very much like the widely
accepted (or even obligated) conventional PCR primer
specificity analysis using default BLAST.  Another impor-
tant problem encountered during methylation analysis is
the difficulty to retrieve methylation assay information for
a given gene of interest by normal literature search tools.
Therefore, we developed a public repository holding
essential assay information (including primer sequences)
for the four major PCR-based methods for DNA methyla-
tion analysis of human, mouse and rat genomes.
Results and discussion
methBLAST
Performing a methBLAST search is similar to and as fast as
regular BLAST [13]. The input page is divided into three
parts. The first component contains a query box and two
input fields for primer sequences. The query box is suited
to paste a sequence in FASTA format. Primer sequence
alignment can be performed by entering the forward and
reverse primer sequence of an assay into the appropriate
input fields. The primer sequences will be concatenated
with three N's when processed by the methBLAST server.
This will guarantee a correct separation of the forward and
reverse sequence during the alignment step. The middle
part lists the query processing options where the target
species and alignment options should be selected. OnlyBMC Bioinformatics 2006, 7:496 http://www.biomedcentral.com/1471-2105/7/496
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alignments against human, mouse and rat sequences from
four different databases are available. The databases con-
tain human, mouse or rat sequences from GenBank [14]
for which complete CpG methylation and bisulphite
modification are simulated. Because of this modification,
the two daughter strands of any given sequence are no
longer complementary after treatment. As either strand
can serve as template for subsequent PCR amplification,
we perform in silico bisulphite modification on both
strands, assuming either an unmethylated or methylated
CpG status. All cytosines (C) are replaced by thymines (T)
– the DNA counterpart of uracil (U) – in sequences
assumed to be completely unmethylated whereas in com-
pletely methylated sequences only the C's not followed by
a G will be replaced resulting in four different sequences
(methylated and unmethylated for each strand) per Gen-
Bank sequence (see Figure 1). The output format is adjust-
able by the options provided in the bottom section. An
output window renders all relevant hits of the test
sequence starting with the best alignments (see Figure 2).
Depending on the database used, the sequence similarity
search will be performed on either forward and reverse
complement methylated (BISUL_METH_FW,
BISUL_METH_RC), or forward and reverse complement
unmethylated sequences (BISUL_UNMETH_FW,
BISUL_UNMETH_RC). The user has to interpret the out-
put in the same way like the BLAST output of a primer pair
for normal PCR applications. A hit is only relevant if this
reveals alignment of the primers at a distance close
enough to generate exponential amplification. A well
designed primer pair aligns exclusively with the target
region, ranked high in the BLAST output. Partial align-
ment of the primers within a short distance on a different
genomic location indicates that an assay using these prim-
ers could be aspecific and thus less reliable. Especially par-
tial alignment of the 3' end of the primers increases the
change of aspecific amplification. The methBLAST results
of 14 different methBLAST searches shown in Table 1, dis-
play the differences in 'Score' and 'E value' of correct align-
ments which are mostly influenced by the primer length
and constitution. It is impossible to use thresholds for the
'Score' and 'E value' to analyse a methBLAST output
because correct alignments and misalignments show over-
lapping values between different primer pairs.
Errors in primer sequences leading to incorrect alignments
can be quickly identified after a methBLAST search. To
demonstrate the usefulness of methBLAST we performed
an MSP analysis of the CDKN2A gene using the primers
and procedures published in [15]. However, we never suc-
ceeded in obtaining a PCR product (data not shown) and
therefore evaluated the primers from [11] (submitted in
methPrimerDB (see further) with ID 17). This assay was
successful upon first attempt (data not shown) and the
methBLAST outputs of both primer sets show correct
alignment with the target sequence (see #11 and #12 in
Table 1). On the other hand the primer sets published in
[15] show only incomplete or even unsuccessful align-
ment (see #13 and #14 in Table 1). The forward primers
of both assays are identical but the reverse primers from
Ueki et. al. appear to contain sequence errors that caused
alignment problems in methBLAST and subsequent
experimental failure (see Table 2).
methPrimerDB
If a custom designed PCR methylation assay passes the in
silico  specificity requirements (determined by meth-
BLAST) and further experimental evaluation, submission
of the assay information in methPimerDB is encouraged.
In addition, authors of publications in which methyla-
tion-specific PCR, Bisulphite-PCR-SSCP, Ms-SNuPE,
COBRA or BiSeq assays are developed, are kindly invited
to submit their validated primer sequences. On-line data
submissions are possible after free registration. During
registration, personal submitter details are provided, after
which an email is sent with the login name and a tempo-
rary password. By changing this password to a more con-
venient one, the registration is complete and the user can
log in to the system and submit primer sets. For submis-
sion of large datasets, a compressed file is available in the
download section of the website which contains the
guidelines to complete an empty provided table with the
required information.
New primer records should contain the official gene
name, the species name, the application in which the
primers are used, the nucleotide sequences of the primers,
and other assay specific fields. In addition, each record
provides the possibility to add submitter's remarks. Data
submissions for DNA methylation analysis on human, rat
and mouse are allowed, as for these organisms proper
controls with respect to accuracy of the gene name fields
are available via Entrez Gene [16] and the nomenclature
databases for these organisms: HGNC (HUGO Gene
Nomenclature Committee) [17] for human, MGD
(Mouse Genome Database) [18] for mouse, and Ratmap
[19] and RGD (Rat Genome Database) [20] for rat. This
eliminates the presence of aliases or synonyms for official
gene symbols in the database. Finally, the possibility to
link the PubMed ID of an article in which the use of a PCR
methylation assay is reported, makes the record more
trustworthy.  The web based search engine makes it possi-
ble to query the database in different ways by type of
application, organism, gene name/symbol, primer
sequence, Entrez Gene ID, PubMed ID, or submitter's
name.  Search results are listed as a summary of links to
individual assay reports (see Figure 3). Each primer set has
a unique methPrimerDB identifier to access them directly
or refer to in a publication (see Figure 4).  Data integrity
checks are performed during the data submission proce-BMC Bioinformatics 2006, 7:496 http://www.biomedcentral.com/1471-2105/7/496
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dure. To guarantee data accuracy, the sequences in the
database will be analysed on regular intervals by meth-
BLAST search. Upon detection of possible sequence or
other errors, the responsible submitter will be contacted
by email.
We are planning to implement an additional feature in
methPrimerDB to store the valuable feedback on assay
performance from users who tested an assay from the
database. The extension of the submitter's feedback sec-
tion with the experimental evaluation details provided by
the submitter as well as user's feedback will allow a better
assessment of the quality of an individual assay. Although
methPrimerDB is developed to let authors submit their
own validated assays, we will populate the database in the
near future with manually reviewed assays from recent lit-
erature.
Conclusion
methBLAST and methPrimerDB are web-tools to improve
the design and use of PCR-based methylation assays. A
sequence homology search for methylation primers with
methBLAST enables specificity assessment before experi-
mental evaluation of a new assay. To reduce the labour-
intensive design of new assays, validated methylation
assays can now be stored and retrieved in methPrimerDB,
a public accessible database. The database is intended to
be a search portal for validated methylation assays and
aims to establish a certain level of standardization and
uniformity in the use of PCR based methylation assays.
Methods
Both systems run on an Apache web server in a Linux envi-
ronment. methBLAST is based on NCBI's BLAST server.
The databases are generated by an in house developed Perl
script (available upon request) converting a subset of the
NCBI's nt database that contains all non-redundant Gen-
Bank+EMBL+DDBJ+PDB nucleotide sequences (but no
EST, STS, GSS, or phase 0, 1 or 2 HTGS sequences). meth-
PrimerDB data is stored and managed by an Oracle 9i
relational database management system. The web inter-
face to query the database is based on PHP scripts using
the Oracle Call Interface (OCI). The database information
and passwords are protected by the Oracle database man-
agement system which controls the access rights to the dif-
ferent tables.
Availability and requirements
Free access to methBLAST http://medgen.ugent.be/meth
blast and methPrimerDB http://medgen.ugent.be/meth
primerdb is possible in a platform independent way by
web browsers supporting image and JavaScript process-
ing. The web sites are hosted by an Apache web server in a
Linux environment. The dynamic web pages are generated
by PHP scripts using the Oracle Call Interface (OCI) to
connect to an Oracle database in which all methPrimerDB
records and related tables are stored. methBLAST is based
on NCBI's BLAST server and an in house developed Perl
script is used to generate the sequence databases contain-
ing the in silico methylated and bisulphite treated
sequences. The Perl code is available for downloading (see
Additional file 1).  We welcome your feedback with
respect to the methPrimerDB interface or content. You
may use the feedback form available from each page or
send comments to methPrimerDB@medgen.UGent.be or
methBLAST@medgen.UGent.be.
Authors' contributions
FP conceived the study, carried out the development of
methPrimerDB, manages and populated the database,
Sequence modifications during bisulphite conversion and sub- sequent PCR amplification of a methylated (left) or unmethyl- ated (right) sequence Figure 1
Sequence modifications during bisulphite conversion and sub-
sequent PCR amplification of a methylated (left) or unmethyl-
ated (right) sequence. CpG dinucleotide locations are bold 
red and underlined; non-CpG cytosine locations are bold 
blue. BISUL_METH_FW, BISUL_METH_RC, 
BISUL_UNMETH_FW, and BISUL_UNMETH_RC are the 
sequence identifiers in the methBLAST databases (see Figure 
2 for example).BMC Bioinformatics 2006, 7:496 http://www.biomedcentral.com/1471-2105/7/496
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methBLAST output (top hits) showing correct alignment of an MSP primer pair for detecting unmethylated CpG's in the pro- moter of the human VHL gene Figure 2
methBLAST output (top hits) showing correct alignment of an MSP primer pair for detecting unmethylated CpG's in the pro-
moter of the human VHL gene. The tag [BISUL_UNMETH_FW] in the sequence heading indicates that it concerns a forward 
(FW) sequence that is bisulphite converted (BISUL) and for which the methylation status is unmethylated (UNMETH).BMC Bioinformatics 2006, 7:496 http://www.biomedcentral.com/1471-2105/7/496
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participated in the development of methBLAST and
drafted the manuscript. JH tested the usefulness of meth-
BLAST by experimental evaluation of MSP primers and
participated in methPrimerDB data submission. PR devel-
oped and manages methBLAST and participated in the
deployment of the BLAST software. EM participated in the
experimental evaluation of methBLAST and participated
in the methPrimerDB data submission. ADP and FS coor-
dinated the study and provided critical input for the man-
uscript. GB, DC and RH carried out the deployment of the
Table 2: Sequence comparison of primers from two CDKN2A MSP assays
Ref.| methPrimerDB ID Template Forward primer sequence Reverse primer sequence
[11] | methPrimerDB ID 17 Unmethylated DNA TTATTAGAGGGTGGGGTGGATTGT CAACCCCAAACCACAACCATAA
[11] | methPrimerDB ID 17 Methylated DNA TTATTAGAGGGTGGGGCGGATCGC GACCCCGAACCGCGACCGTAA
[15] | - Unmethylated DNA TTATTAGAGGGTGGGGTGGATTGT CAACCCCAAACCCACAACCATAA
[15] | - Methylated DNA TTATTAGAGGGTGGGGCGGATCGC GACCCCCGAACCGCGACCCTAA
The primer pairs from methPrimerDB ID 17 can generate a specific PCR product and show correct alignment with the target sequence when 
performing a methBLAST analysis (see Table 1). The primers published in [15] have identical forward primer sequences but the reverse primer 
sequence for detecting unmethylated DNA contains a cytosine insert between positions 12 and 13 and the reverse primer sequence for detecting 
methylated DNA contains a cytosine insert between positions 6 and 7 and a substitution from guanine to cytosine at position 18 (see nucleotides in 
bold and underlined). These sequence errors make the assay non-functional.
Table 1: methBLAST results of a panel of assays from methPrimerDB (1–12) and literature (13–14).
Best hit when both primers align on correct target First misalignment
# ID Assay type Gene symbol Sequence identifier Score (bits) E value Sequence identifier Score (bits) E value
1 14 BiPS VHL gb|L15409.1| [BISUL_METH_RC] 40.1 (20) 0.32 dbj|D64176.1| 
[BISUL_METH_RC]
32.2 (16) 79
2 236 BiPS NKX3-1 gb|U91540.1| 
[BISUL_UNMETH_FW]
46.1 (23) 0.007 dbj|AP005361.2| 
[BISUL_UNMETH_RC]
44.1 (22) 0.026
3 26 Ms-SNuPE RARB emb|X56849.1| 
[BISUL_UNMETH_FW]
44.8 (22) 0.015 dbj|AP001217.3| 
[BISUL_UNMETH_RC]
40.8 (20) 0.25
4 28 Ms-SNuPE CDKN2A dbj|AB060808.1| 
[BISUL_UNMETH_RC]
46.1 (23) 0.007 emb|AL590456.5| 
[BISUL_UNMETH_RC]
40.1 (20) 0.41
5 13 COBRA ESR1 gb|M69297.1| 
[BISUL_UNMETH_RC]
46.1 (23) 0.006 gb|AE014307.1| 
[BISUL_UNMETH_RC]
40.1 (20) 0.40
6 16 COBRA FLT1 emb|AL139005.12| 
[BISUL_UNMETH_RC]
40.8 (20) 0.22 emb|AL731546.4| 
[BISUL_UNMETH_FW]
38.8 (19) 0.91
7 24 BiSeq CDKN2C gb|AY094608.1| 
[BISUL_UNMETH_FW]
50.1 (25) 4e-04 gb|AC027334.5| 
[BISUL_UNMETH_FW]
40.1 (20) 0.43
8 83 BiSeq SERPINB5 gb|AC036176.8| 
[BISUL_UNMETH_RC]
60.0 (30) 7e-07 emb|AL133413.5| 
[BISUL_UNMETH_FW]
52.0 (26) 2e-04
9 1 MSP-unmeth VHL gb|AC018808.5| 
[BISUL_UNMETH_RC]
48.1 (24) 0.002 emb|AL513423.3| 
[BISUL_UNMETH_RC]
44.1 (22) 0.025
10 1 MSP-meth VHL gb|L15409.1| 
[BISUL_METH_FW]
44.1 (22) 0.021 gb|AC079148.9| 
[BISUL_METH_FW]
36.2 (18) 5.1
11 17 MSP-unmeth CDKN2A dbj|AB060808.1| 
[BISUL_UNMETH_RC]
48.1 (24) 0.002 emb|AL137127.7| 
[BISUL_UNMETH_RC]
42.1 (21) 0.11
12 17 MSP-meth CDKN2A gb|AF044170.1| 
[BISUL_METH_FW]
48.1 (24) 0.002 emb|AL137077.31| 
[BISUL_METH_RC]
36.2 (18) 6.4
13 Ref [15] MSP-unmeth CDKN2A dbj|AP001626.1| 
[BISUL_UNMETH_RC]
38.2 (19) 1.7 emb|AL161774.49| 
[BISUL_UNMETH_FW]
44.1 (22) 0.028
14 Ref [15] MSP-meth CDKN2A Na Na Na gb|AC092171.4| 
[BISUL_METH_FW]
38.2 (19) 1.7
This list summarizes the output of 14 individual methBLAST searches. We randomly selected two assays from the five assay types available in 
methPrimerDB and listed the sequence identifier, the score and E value of the best hit when both the forward and reverse primer align correctly on 
the desired target and of the first alignment on an undesired target sequence. The MSP assays have two primer pairs resulting in two methBLAST 
outputs (9–14). All misalignment hits are the result from partial alignment of one of the primers of an assay. This does not result in aspecific 
amplification. The alignments of the primers from the assays submitted in methPrimerDB are correct and do not demonstrate any potentially 
amplifiable misalignments. Alignment results #13 and #14 were generated with primers published in literature [15] that are almost identical to the 
primers from methPrimerDB ID 17 for which the results are numbered as #11 and #12. Result #13 shows correct but incomplete alignment 
compared to result #12 and attempt #14 does not lead to any correct alignment.
Abbreviations: ID: methPrimerDB ID; BiPS: PCR-single-strand conformation polymorphism analysis; Ms-SNuPE: methylation-sensitive single-
nucleotide primer extension; COBRA: combined bisulphite restriction analysis; BiSeq: Bisulphite Sequencing; MSP-unmeth: methylation-specific PCR 
for unmethylated target detection; MSP-meth: methylation-specific PCR for methylated target detectionBMC Bioinformatics 2006, 7:496 http://www.biomedcentral.com/1471-2105/7/496
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methPrimerDB search result snapshot listing the assays in a table containing the ID (direct link to the assay report), the species  abbreviation, the gene symbol and name, the methylation analysis method and user remarks (if provided) Figure 3
methPrimerDB search result snapshot listing the assays in a table containing the ID (direct link to the assay report), the species 
abbreviation, the gene symbol and name, the methylation analysis method and user remarks (if provided).BMC Bioinformatics 2006, 7:496 http://www.biomedcentral.com/1471-2105/7/496
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Assay report for methPrimerDB ID 1 consists of five parts containing gene annotation information, primer sequences, a publi- cation reference, if applicable a direct link to the qPCR gene expression assay database RTPrimerDB [21] and the submitter's  contact details Figure 4
Assay report for methPrimerDB ID 1 consists of five parts containing gene annotation information, primer sequences, a publi-
cation reference, if applicable a direct link to the qPCR gene expression assay database RTPrimerDB [21] and the submitter's 
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BLAST software. JV conceived the study, participated in its
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